Clinical Trial Update: 18F-DOPA-PET in Non-tumoral and Tumoral Brain Lesions

View source ↗

Summary

A completed clinical trial evaluating 18F-DOPA-PET imaging in non-tumoral and tumoral brain lesions conducted by Centre Hospitalier Universitaire de Nîmes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• 18F-DOPA (fluorodopa)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Brain Tumor | Status: COMPLETED